Ensign Peak Advisors, Inc Shockwave Medical, Inc. Transaction History

Ensign Peak Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $23.6 Million - $40.2 Million	-123,455 Reduced 38.78%	194,887 $63.5 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $49.5 Million - $66.3 Million	307,362 Added 2799.29%	318,342 $60.7 Million
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $98,136 - $143,404	-505 Reduced 4.4%	10,980 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $112,640 - $152,853	505 Added 4.6%	11,485 $3.28 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $201,721 - $250,608	1,150 Added 11.7%	10,980 $2.38 Million
Q4 2022 Feb 13, 2023	BUY	$204.38 - $296.82 $153,285 - $222,615	750 Added 8.26%	9,830 $2.02 Million
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $168,069 - $310,996	1,450 Added 19.0%	9,080 $1.74 Million
Q4 2021 Feb 11, 2022	BUY	$165.13 - $241.83 $1.26 Million - $1.85 Million	7,630 New	7,630 $1.36 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.